P1: PSB Printer: Yet To Come
9780521704632c15 CUFX213A/Peck 9780521618168 December 28, 2007 13:25
Section IIICardiovascular drugs
Table 15.2.Various pharmacological properties of some Ca^2 +channel antagonists.
Absorbed
(%)
Oral bioavail-
ability (%)
Protein
binding (%)
Active
metabolites Clearance
Elimination
half-life (h)
Verapamil 95 20 90 yes renal 6–12
Nifedipine 95 60 95 no renal 2–5
Diltiazem 95 50 75 yes 60% hepatic,
40% renal
3–6
coronary artery blood flow and reflex increases in heart rate and contractility. The
cardiac output is increased. Occasionally these reflex changes worsen the oxygen
supply/demand ratio.
Kinetics
Nifedipine is well absorbed following oral administration although hepatic first-
pass metabolism reduces its oral bioavailability to 60%. It is 95% plasma protein-
bound and has an elimination half-life of 5 hours following oral administration. It is
predominantly excreted as inactive metabolites in the urine (Table15.2).
Nimodipine
Nimodipine is a more lipid-soluble analogue of nifedipine and as such can penetrate
the BBB. It is used in the prevention and treatment of cerebral vasospasm follow-
ing subarachnoid haemorrhage and in migraine. It may be administered orally or
intravenously.
Its action may be dependent on blocking a Ca^2 +-dependent cascade of cellular
processes that would otherwise lead to cell damage and destruction.
Diltiazem
Presentation and uses
Diltiazem is available as 60–200 mg tablets, some of which are available as slow
release. It is also available in combination with hydrochlorothiazide. It is used for
the prophylaxis and treatment of angina and in hypertension.
Effects
Cardiovascular – diltiazem has actions both within the heart and in the peripheral
circulation. It prolongs AV conduction time and reduces contractility but to a lesser
extent than verapamil. It also reduces the systemic vascular resistance and the
blood pressure falls although a reflex tachycardia is not usually seen. Coronary
blood flow is increased due to coronary artery vasodilation.